Journal of Nuclear Medicine: 64 (3)

March 1, 2023; Volume 64,Issue 3

Cover image

FEATURED ARTICLE

PET Imaging of Fibroblast Activation Protein in Various Types of Cancer Using ⁶⁸Ga-FAP-2286: Comparison with ¹⁸F-FDG and ⁶⁸Ga-FAPI-46 in a Single-Center, Prospective Study. Yizhen Pang et al. See page 386.

In this issue

Issue highlights

PET Imaging of Fibroblast Activation Protein in Various Types of Cancer Using ⁶⁸Ga-FAP-2286: Comparison with ¹⁸F-FDG and ⁶⁸Ga-FAPI-46 in a Single-Center, Prospective Study
Development of a Lensless Radiomicroscope for Cellular-Resolution Radionuclide Imaging

First-in-Human Assessment of ¹¹C-LSN3172176, an M1 Muscarinic Acetylcholine Receptor PET Radiotracer
Performance Evaluation of the uEXPLORER Total-Body PET/CT Scanner Based on NEMA NU 2-2018 with Additional Tests to Characterize PET Scanners with a Long Axial Field of View
Slow but Evident Recovery from Neocortical Dysfunction and Cognitive Impairment in a Series of Chronic COVID-19 Patients
Tumor Response to Radiopharmaceutical Therapies: The Knowns and the Unknowns
Is FDG maximum standardized uptake value (SUV max) of primary breast cancer can predict axillary lymph node metastasis?

More...

Main menu

User menu

Search

Table of Contents

Cover image

In this issue

Issue highlights

Jump to